| |
| Issue |
Title |
| |
| Vol 13, No 1 (2025) |
Brain-derived neurotrophic factor as a target for the search of anti-addiction drugs |
Abstract
PDF (Rus)
PDF (Eng)
|
|
M. S. Khalimanov, E. M. Grigorevskikh, K. A. Zavadich, S. I. Sologov, D. A. Traschenkova, K. A. Tatzhikova, E. V. Polikarpov, S. S. Sologova, D. A. Kudlay, E. A. Smolyarchuk |
| |
| Vol 13, No 1 (2025) |
A rational approach to dose reduction of CDK4/6 inhibitors in the treatment of patients with advanced breast cancer: A narrative Review |
Abstract
PDF (Rus)
PDF (Eng)
|
|
I. N. Dyakov, S. K. Zyryanov |
| |
| Vol 12, No 6 (2024) |
Original drugs approved by the Food and Drug Administration (Center for Drug Evaluation and Research) in 2024 |
Abstract
PDF (Rus)
PDF (Eng)
|
|
D. V. Kurkin, N. A. Osadchenko, A. R. Makarova, D. A. Galkina, D. A. Bakulin, O. V. Shatalova, A. V. Strygin, V. I. Petrov, O. V. Marincheva, Yu. V. Gorbunova, Yu. A. Kolosov, A. V. Zaborovsky, D. V. Yunina, K. N. Koryanova, E. I. Morkovin, M. A. Dzhavakhyan, V. I. Zvereva, R. V. Drai, I. E. Makarenko, A. S. Shuvaeva |
| |
| Vol 12, No 5 (2024) |
Treatment approaches to pulmonary lymphangioleomyomatosis: From surgical extirpation to molecular biology |
Abstract
PDF (Rus)
PDF (Eng)
|
|
I. V. Polovnikov, G. Yu. Yukina, E. G. Sukhorukova |
| |
| Vol 12, No 5 (2024) |
Targeted therapy of bronchial asthma in children and adolescents: А narrative review |
Abstract
PDF (Rus)
PDF (Eng)
|
|
M. S. Matevosova, L. I. Agapitov, I. A. Averina, I. V. Sokolova, S. V. Zotova, R. A. Chernigovskiy |
| |
| Vol 12, No 4 (2024) |
The work of compounding pharmacies and the possible risks of violating the exclusive rights to original medicines |
Abstract
PDF (Rus)
PDF (Eng)
|
|
A. V. Alekhin, T. N. Erivantseva, V. O. Kalyatin, R. A. Ivanov, N. A. Alekhina |
| |
| Vol 12, No 5 (2024) |
The current state of the problem of treatment adherence in patients with osteoporosis |
Abstract
PDF (Rus)
PDF (Eng)
|
|
A. M. Beitullaev, E. A. Egorova, A. V. Petrov, K. V. Bubley, A. V. Matveev, A. A. Bikbaev, A. G. Gevorkyan, T. K. Maltsev, M. N. Usamova |
| |
| Vol 12, No 5 (2024) |
Regulation in the sphere of circulation of extemporaneously compounded medicines under modern conditions of Russia |
Abstract
PDF (Rus)
PDF (Eng)
|
|
V. V. Ryazhenov, E. A. Maksimkina, V. S. Fisenko, A. V. Alekhin, V. V. Tarasov, M. G. Raisyan, E. R. Zakharochkina, K. A. Chizhov, R. Yu. Garankina |
| |
| Vol 12, No 2 (2024) |
Spiramycin: The past and future of an antibiotic with pleiotropic effects in the therapy of community-acquired infections |
Abstract
PDF (Rus)
PDF (Eng)
|
|
O. I. Butranova, S. K. Zyryanov, A. A. Abramova |
| |
| Vol 12, No 2 (2024) |
Review of BRICS regulatory practices in the field of drugs compounding |
Abstract
PDF (Rus)
PDF (Eng)
|
|
D. S. Yurochkin, D. D. Mamedov, S. E. Erdni-Garyaev, A. V. Yarutkin, V. L. Bagirova, P. S. Guryanov, O. Loudiyi, W. Li |
| |
| Vol 12, No 1 (2024) |
Use of gabapentin for neuropathic pain therapy: A view from perspective of evidence-based medicine |
Abstract
PDF (Rus)
PDF (Eng)
|
|
O. I. Butranova, S. K. Zyryanov |
| |
| Vol 11, No 6 (2023) |
Terpenoids and phenolic compounds as biologically active compounds of medicinal plants with diuretic effect |
Abstract
PDF (Rus)
PDF (Eng)
|
|
V. A. Kurkin, O. E. Pravdivtseva, E. N. Zaitseva, A. V. Dubishchev, A. S. Tsibina, A. V. Kurkina, S. V. Pervushkin, A. V. Zhdanova |
| |
| Vol 11, No 5 (2023) |
Methodological and regulatory aspects of pharmaceutical development of biological products |
Abstract
PDF (Rus)
PDF (Eng)
|
|
D. V. Kurkin, E. I. Morkovin, D. A. Bakulin, A. V. Zaborovsky, I. E. Makarenko, R. V. Drai, A. G. Solodovnikov, V. I. Petrov, K. N. Koryanova, N. A. Lycheva, S. A. Voskresensky, A. V. Strygin, Yu. A. Kolosov, Yu. V. Gorbunova, O. V. Ivanova |
| |
| Vol 11, No 5 (2023) |
Phenylpropanoids as a class of natural biologically active organo-protective compounds |
Abstract
PDF (Rus)
PDF (Eng)
|
|
V. A. Kurkin, N. R. Varina, E. V. Avdeeva, I. V. Ruzaeva |
| |
| Vol 11, No 5 (2023) |
Review of publications on drug-related problems investigations in osteoporosis patients |
Abstract
PDF (Eng)
PDF (Rus)
|
|
E. A. Egorova, A. M. Beitullaev, A. V. Matveev, K. N. Koryanova |
| |
| Vol 11, No 3 (2023) |
Past, current and future of legal regulation of drugs compounding in the Russian Federation |
Abstract
PDF (Rus)
PDF (Eng)
|
|
D. D. Mamedov, D. S. Yurochkin, Z. M. Golant, V. S. Fisenko, A. V. Alekhin, I. A. Narkevich |
| |
| Vol 11, No 3 (2023) |
Overview of drugs approved by the FDA in 2022 |
Abstract
PDF (Rus)
PDF (Eng)
|
|
D. V. Kurkin, E. I. Morkovin, D. A. Bakulin, Yu. V. Gorbunova, Yu. A. Kolosov, M. A. Dzhavakhyan, I. E. Makarenko, R. V. Drai, A. V. Zaborovsky, O. V. Shatalova, A. V. Strygin, V. I. Petrov, A. P. Pleten, A. A. Prokopov, T. Yu. Tatarenko-Kozmina |
| |
| Vol 11, No 2 (2023) |
“Off-label” drugs: legal problems and socio-economic aspects of application practice |
Abstract
PDF (Rus)
PDF (Eng)
|
|
S. V. Russkikh, E. A. Tarasenko, L. I. Moskvicheva, S. A. Orlov, A. A. Tryakin, A. V. Vorobeva, O. A. Beneslavskaya, V. I. Makarova, E. A. Putilina, S. A. Utkin |
| |
| Vol 11, No 2 (2023) |
New role of extemporaneous manufacturing in regulating drug products access onto the market |
Abstract
PDF (Rus)
PDF (Eng)
|
|
A. V. Alekhin, T. N. Erivantseva, V. V. Ryazhenov, N. N. Lyskov, N. A. Alekhina, M. M. Kuznetsova |
| |
| 1 - 19 of 19 Items |
|
